Ventricular Tachycardia Cycle Length and Response to Rhythm Control Therapy: Insights From the VANISH Trial.

Saved in:
Bibliographic Details
Title: Ventricular Tachycardia Cycle Length and Response to Rhythm Control Therapy: Insights From the VANISH Trial.
Authors: Samuel M; Mario Lemieux Center for Heart Rhythm Care, Allegheny Health Network, Pittsburgh, Pennsylvania, USA; Drexel University, Philadelphia, Pennsylvania, USA; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada., Parkash R; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada., Healey JS; Population Health Research Institute, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada., Nault I; Quebec Heart and Lung Institute, Quebec, Canada., Blier L; Quebec Heart and Lung Institute, Quebec, Canada., Gray C; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada., Sapp JL; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: John.Sapp@nshealth.ca.
Source: JACC. Clinical electrophysiology [JACC Clin Electrophysiol] 2025 Nov; Vol. 11 (11), pp. 2528-2531. Date of Electronic Publication: 2025 Oct 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101656995 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-5018 (Electronic) Linking ISSN: 2405500X NLM ISO Abbreviation: JACC Clin Electrophysiol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2405-5018
DOI:10.1016/j.jacep.2025.08.025